Rhabdomyosarcoma with TFCP2 Rearrangement or Typical Co-expression of AE1/AE3 and ALK: Report of Three New Cases in the Head and Neck Region and Literature Review
- 14 November 2022
- journal article
- review article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 17 (2) , 546-561
Abstract
Background Rhabdomyosarcoma (RMS) harboring EWSR1/FUS-TFCP2 fusions has been recently described as a distinct form of RMS with an aggressive course and predilection for the craniofacial bones, especially the jaws. Methods We report three new cases of this rare entity, two from Brazil and one from Guatemala, with detailed clinicopathologic, immunohistochemical, and molecular descriptions. Additionally, we explored the English-language literature searching RMS with TFCP2 rearrangement or typical immunophenotype with co-expression of AE1/AE3 and ALK in the head and neck region. Results Case 1 is a 58-year-old male with a 3-month history of painful swelling in the anterior maxilla. Case 2 is a 22-year-old male presenting with right facial swelling and proptosis. Case 3 is a 43-year-old female with a rapidly growing tumor located in the zygomatic region. Imaging examinations revealed highly destructive intraosseous masses in the first two cases, and a soft tissue tumor with bone invasion in case 3. Microscopically, all cases showed a hybrid spindle and epithelioid phenotype of tumor cells which expressed desmin, myogenin and/or Myo-D1, AE1/AE3, and ALK. FISH confirmed molecular alterations related to TFCP2 rearrangement in Cases 1–2. In case 3, there was no available material for molecular analysis. The patients were subsequently referred to oncologic treatment. Additionally, we summarized the clinicopathologic, immunohistochemical, and molecular features of 27 cases of this rare RMS variant in the head and neck region reported in the English-language literature. Conclusion RMS with TFCP2 rearrangement is a rare and aggressive tumor with a particular predilection for craniofacial bones, especially the jaws. Knowing its clinicopathologic and immunohistochemical profile can avoid misdiagnosis.Keywords
This publication has 19 references indexed in Scilit:
- A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulationLaboratory Investigation, 2020
- Expanding the Spectrum of Intraosseous RhabdomyosarcomaAmerican Journal of Surgical Pathology, 2019
- Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendotheliomaLaboratory Investigation, 2019
- Rhabdomyosarcoma with FUS re-arrangement: additional case in support of a novel subtypePathology, 2019
- Spindle cell rhabdomyosarcoma of bone with FUS–TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtypeHistopathology, 2018
- Transcriptomic definition of molecular subgroups of small round cell sarcomasThe Journal of Pathology, 2018
- Head and neck rhabdomyosarcoma in children: a 20-year retrospective study at a tertiary referral centerJournal of Cancer Research and Clinical Oncology, 2017
- RhabdomyosarcomaSeminars in Pediatric Surgery, 2016
- Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein FamilySarcoma, 2010
- Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfallLaboratory Investigation, 2008